SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.932
AS - Asia 6.331
EU - Europa 4.326
SA - Sud America 1.235
AF - Africa 124
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 8
AN - Antartide 1
Totale 24.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.664
SG - Singapore 2.556
CN - Cina 1.888
BR - Brasile 1.046
IT - Italia 1.032
DE - Germania 776
HK - Hong Kong 582
UA - Ucraina 540
PL - Polonia 417
TR - Turchia 416
GB - Regno Unito 412
VN - Vietnam 378
FI - Finlandia 289
SE - Svezia 206
RU - Federazione Russa 193
CA - Canada 150
ID - Indonesia 137
FR - Francia 127
MX - Messico 92
IN - India 90
AR - Argentina 73
JP - Giappone 67
NL - Olanda 66
ZA - Sudafrica 60
BD - Bangladesh 53
BE - Belgio 47
AT - Austria 41
ES - Italia 37
LT - Lituania 32
EC - Ecuador 31
CZ - Repubblica Ceca 30
IQ - Iraq 25
CO - Colombia 23
CH - Svizzera 21
CL - Cile 18
VE - Venezuela 18
UZ - Uzbekistan 17
PK - Pakistan 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
KE - Kenya 13
MA - Marocco 12
IE - Irlanda 11
IL - Israele 11
KR - Corea 10
PY - Paraguay 10
TN - Tunisia 10
JO - Giordania 9
AU - Australia 8
EU - Europa 8
PT - Portogallo 8
DZ - Algeria 7
EG - Egitto 7
PE - Perù 7
IR - Iran 6
JM - Giamaica 6
LV - Lettonia 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
HU - Ungheria 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
UY - Uruguay 4
CG - Congo 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GE - Georgia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
LB - Libano 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CD - Congo 1
CY - Cipro 1
GD - Grenada 1
Totale 24.952
Salva come PNG Salva come JPEG
Città #
Ashburn 1.436
Singapore 1.409
Fairfield 1.187
Woodbridge 1.155
Chandler 795
Houston 732
Beijing 721
Ann Arbor 709
Santa Clara 621
Jacksonville 616
Hong Kong 579
Seattle 499
Wilmington 470
Cambridge 421
Warsaw 405
Ferrara 362
Los Angeles 291
Dallas 252
Munich 248
Izmir 236
Nanjing 169
Princeton 163
New York 160
Shanghai 133
Milan 120
Boardman 115
Jakarta 115
Ho Chi Minh City 114
San Diego 105
São Paulo 99
Turku 90
Hanoi 84
Helsinki 77
Buffalo 74
London 72
The Dalles 60
Mexico City 59
Tianjin 59
Bremen 57
Chicago 57
Tokyo 56
Nanchang 53
Bologna 50
Shenyang 49
Montreal 48
Toronto 48
Dearborn 47
Frankfurt am Main 46
Denver 45
Brooklyn 44
Brussels 44
Hefei 42
Chennai 40
Orem 40
Stockholm 38
San Francisco 37
Hebei 36
Jiaxing 35
Johannesburg 35
Boston 34
Council Bluffs 34
Falls Church 34
Moscow 33
Falkenstein 32
Phoenix 32
Changsha 30
Nuremberg 30
Poplar 28
Columbus 27
Atlanta 25
Belo Horizonte 25
Auburn Hills 24
Manchester 24
Rio de Janeiro 24
Zhengzhou 24
Ankara 23
Brno 23
Norwalk 23
Dong Ket 22
Amsterdam 21
Mountain View 21
Porto Alegre 21
Washington 21
Guangzhou 20
Curitiba 18
Jinan 17
Kunming 17
Zurich 17
Augusta 16
Brasília 16
Des Moines 16
Orange 16
San Jose 16
Haiphong 15
Ottawa 15
Rome 15
Salvador 15
Tashkent 15
Addison 14
Da Nang 14
Totale 16.866
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 344
Pharmacology of Adenosine Receptors: The State of the Art 295
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 254
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 243
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 238
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 236
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 235
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 230
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 229
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 226
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 226
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 221
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 220
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 218
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 217
The A3 adenosine receptor: history and perspectives 216
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 214
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 212
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 210
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 210
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 206
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 205
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 195
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 195
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 195
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 190
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 189
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 179
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 179
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
Pathological overproduction: the bad side of adenosine 178
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 177
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 177
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 176
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 176
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 175
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 175
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 174
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 173
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 172
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 171
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 171
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 170
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 170
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 170
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 168
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 167
Development of novel pyridazinone-based adenosine receptor ligands 165
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 164
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 163
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 161
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 160
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 158
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 156
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 155
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 154
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 154
Targeting A3 and A2A adenosine receptors in the fight against cancer 154
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 153
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 152
The role of adenosine receptors in rheumatoid arthritis. 152
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 149
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 149
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E2 and cytokine production in human osteoarthritic synovial fibroblasts 148
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 148
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 145
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 145
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 144
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 143
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 143
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 143
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 143
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 142
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 142
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 138
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 135
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 133
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 132
A2A adenosine receptors and chronic caffeine intake in human neutrophils 129
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 129
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 127
Effect of Pulsed Electromagnetic Field Exposure on Adenosine Receptors in Human Fibroblast-like Synoviocytes 125
Pharmacological characterization of P2X1 and P2X3 purinergic receptors in bovine chondrocytes 124
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 124
Anxiolytic properties of A1 adenosine receptor PAMs 124
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 124
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 123
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 121
null 121
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 120
Modifications on the amino-3,5-dicyanopyridine core to obtain multifaceted adenosine receptor ligands with antineuropathic activity 120
A1 Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic? 117
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 117
A2A adenosine receptors and chronic caffeine intake in human neutrophils 116
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 115
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition (dagger). 114
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 112
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils. 111
Totale 16.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.529
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.099
Totale 122.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.719 0 0 0 0 0 254 186 321 111 423 289 135
2021/20221.497 46 155 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20255.044 109 151 374 288 469 510 241 284 803 515 695 605
2025/20266.780 1.329 544 1.110 1.570 2.017 210 0 0 0 0 0 0
Totale 25.369